Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-02

Clinical Trial Update: CNS Study of Patients Switching From Tacrolimus to Envarsus [Phase 4]

View source ↗

Summary

Phase 4 trial update on switching renal transplant patients from tacrolimus to Envarsus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Envarsus (tacrolimus)
  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Renal Transplant Patients | Phase 4 | Status: COMPLETED | Results posted: 2022-06-02